Annual ROE
-92.97%
-63.16%-211.88%
December 31, 2024
Summary
- As of March 12, 2025, MLYS annual return on equity is -92.97%, with the most recent change of -63.16% (-211.88%) on December 31, 2024.
- During the last 3 years, MLYS annual ROE has fallen by -177.63% (-209.82%).
- MLYS annual ROE is now -197.61% below its all-time high of 95.25%, reached on December 1, 2020.
Performance
MLYS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-67.97%
-12.05%-21.55%
December 31, 2024
Summary
- As of March 12, 2025, MLYS quarterly return on equity is -67.97%, with the most recent change of -12.05% (-21.55%) on December 31, 2024.
- Over the past year, MLYS quarterly ROE has dropped by -41.49% (-156.68%).
- MLYS quarterly ROE is now -173.74% below its all-time high of 92.17%, reached on June 1, 2022.
Performance
MLYS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MLYS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -211.9% | -156.7% |
| 3 y3 years | -209.8% | -156.7% |
| 5 y5 years | -197.6% | -156.7% |
MLYS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -209.8% | at low | -173.7% | at low |
| 5 y | 5-year | -197.6% | at low | -173.7% | at low |
| alltime | all time | -197.6% | at low | -173.7% | at low |
Mineralys Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -92.97%(+211.9%) | -67.97%(+21.5%) |
| Sep 2024 | - | -55.92%(+31.2%) |
| Jun 2024 | - | -42.61%(+31.2%) |
| Mar 2024 | - | -32.48%(+22.7%) |
| Dec 2023 | -29.81% | -26.48%(-7.3%) |
| Sep 2023 | - | -28.55%(-14.5%) |
| Jun 2023 | - | -33.39%(-36.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -52.21%(-183.8%) |
| Dec 2022 | 57.01%(-32.7%) | 62.29%(-25.7%) |
| Sep 2022 | - | 83.84%(-9.0%) |
| Jun 2022 | - | 92.17%(+44.2%) |
| Mar 2022 | - | 63.91%(+106.8%) |
| Dec 2021 | 84.66%(-11.1%) | - |
| Dec 2021 | - | 30.90% |
| Dec 2020 | 95.25% | - |
FAQ
- What is Mineralys Therapeutics annual return on equity?
- What is the all time high annual ROE for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual ROE year-on-year change?
- What is Mineralys Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly ROE year-on-year change?
What is Mineralys Therapeutics annual return on equity?
The current annual ROE of MLYS is -92.97%
What is the all time high annual ROE for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual return on equity is 95.25%
What is Mineralys Therapeutics annual ROE year-on-year change?
Over the past year, MLYS annual return on equity has changed by -63.16% (-211.88%)
What is Mineralys Therapeutics quarterly return on equity?
The current quarterly ROE of MLYS is -67.97%
What is the all time high quarterly ROE for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly return on equity is 92.17%
What is Mineralys Therapeutics quarterly ROE year-on-year change?
Over the past year, MLYS quarterly return on equity has changed by -41.49% (-156.68%)